Skip to main content
Cytophage Technologies Ltd. logo

Cytophage Technologies Ltd. — Investor Relations & Filings

Ticker · CYTO ISIN · CA2328211081 LEI · 254900L9XZT97QIBN831 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 75 across all filing types
Latest filing 2023-06-01 M&A Activity
Country CA Canada
Listing TSXV CYTO

About Cytophage Technologies Ltd.

https://cytophage.com/

Cytophage Technologies Ltd. is a pioneering biotechnology company focused on developing synthetic bacteriophage products to prevent and treat bacterial infections, aiming to reduce and ultimately replace the use of conventional antibiotics. The company utilizes molecular genetic techniques and proprietary synthetic biology technology to create tailor-made, highly effective phages that are harmless to humans and animals. Cytophage's solutions address three primary markets: Animal Health (e.g., livestock illness prevention and growth enhancement), Food Safety (preventing disease spread without antibiotics), and Human Health (treating bacterial illnesses and hospital decontamination). A key competitive advantage is the rapid production timeline for targeted phages, enabling quick response to bacterial threats. The company is also engaged in advanced research, including the development of genetically engineered phage-based vaccines.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a detailed announcement of a letter of intent (LOI) between Cuspis Capital III Ltd. and Cytophage Technologies Inc. regarding a qualifying transaction involving an arrangement, amalgamation, or share exchange. It includes extensive background on the companies, the transaction terms, management and board composition, and financial highlights of Cytophage. The document does not contain financial statements or detailed financial performance data but rather focuses on the transaction details and corporate governance changes expected post-transaction. This fits the category of M&A Activity announcements, which cover merger proposals or takeover bids and related transaction details. The document is not a full annual or interim report, audit report, earnings release, or regulatory filing. Therefore, the appropriate classification is M&A Activity (TAR).
2023-06-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CEO of Cuspis Capital III Ltd. regarding the review and fair presentation of the interim financial report for the period ending March 31, 2023. It is titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE' and explicitly states it is a certification of interim filings, not the interim report itself. The document contains no actual financial data or substantive financial analysis but rather an attestation of the accuracy and fairness of the interim filings. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (2773 characters), and it is clearly a certification letter, not the report itself.
2023-05-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the Chief Financial Officer regarding the interim financial report and interim MD&A for the period ended March 31, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a venture issuer. The document does not contain actual financial statements or substantive financial data but is an officer certification about the interim filings. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3044 characters), and it is clearly a certification letter, not the interim report or MD&A itself.
2023-05-30 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis of the Financial Condition and Results of Operations' for Cuspis Capital III Ltd. for the three months ended March 31, 2023 and 2022. It includes detailed financial discussion, operating expenses, share capital information, and references to unaudited condensed interim financial statements prepared under IFRS and IAS 34 (Interim Financial Reporting). The presence of detailed financial data and analysis for a period shorter than a full fiscal year (quarterly) confirms this is an Interim / Quarterly Report. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-05-30 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited condensed interim financial statements' for the three months ended March 31, 2023 and 2022. It contains detailed financial statements including statements of financial position, income, changes in equity, cash flows, and notes to the financial statements. The document explicitly states it is prepared under IAS 34 Interim Financial Reporting and IFRS, and it is unaudited. The presence of comprehensive financial data for a period shorter than a full fiscal year (quarterly) and the detailed financial analysis confirms this is an Interim / Quarterly Report. The document is not a brief announcement or a certification, but a full interim financial report.
2023-05-30 English
AB form 13-501F2 (class 2 reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is extremely short (181 characters) and contains no textual content other than dates and placeholders for images. There is no substantive financial data, no report title, no regulatory references, and no detailed information. It does not contain any report or announcement text. Given the lack of content, this is likely a placeholder or a minimal announcement without actual report data. According to the rules, such minimal content without substantive data or report text should be classified as Regulatory Filings (RNS) as a fallback category.
2022-04-29 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.